| Old Articles: <Older 711-720 Newer> |
 |
The Motley Fool January 23, 2004 Whitney Tilson |
Buffettesque Superinvestors The author talks about 12 up-and-coming, mostly unknown investment managers whom he believes will substantially outperform the market over time. They manage money in very different ways, but all are from the intellectual village of Graham-and-Doddsville.  |
The Motley Fool January 23, 2004 Alyce Lomax |
Is UST Up to Snuff? Where there's no smoke, there's UST. While UST's tobacco brands are of the smokeless variety, investors probably got shaky about analysts' ideas of possible smoke on the horizon -- the smoke of a price war, that is.  |
The Motley Fool January 23, 2004 Rich Smith |
Lego Adrift in Space Danish toy maker Lego needs to get back to basics if it is to return to profitability.  |
The Motley Fool January 23, 2004 Alyce Lomax |
Amgen's Engine Is the drug company geared up for success?  |
The Motley Fool January 23, 2004 Tom Taulli |
EMC Buys Success So far, EMC has managed the rare turnaround through M&A.  |
The Motley Fool January 23, 2004 Bill Mann |
Mighty Microsoft Microsoft's earnings dropped 17%. Worried? Don't be, as the change was largely due to Microsoft switching from granting its employees stock options to granting them restricted stock, which is accounted for differently.  |
The Motley Fool January 23, 2004 Rick Aristotle Munarriz |
Set-top, Game, and Match Scientific-Atlanta continues to feast on our couch-potato ways.  |
The Motley Fool January 23, 2004 Rick Aristotle Munarriz |
Callaway's Happy Bertha Day The oversized-club maker is looking for a bigger swing in 2004.  |
BusinessWeek February 2, 2004 Gene G. Marcial |
CV Investors: Take Heart Lately, CV Therapeutics is bouncing around on rumors of what the Food & Drug Administration might do about Ranexa, CV's angina treatment. One New York fund manager, who asked not to be identified, is buying shares because he expects a takeover bid.  |
BusinessWeek February 2, 2004 Roger O. Crockett |
AT&T Wireless: Bidding War, Anyone? Despite its weaknesses, rivals are itching to buy the cellular provider for its bulk.  |
| <Older 711-720 Newer> Return to current articles. |